Cargando…

Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

Pharmacotherapy is the most common treatment for schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). Pharmacogenetic studies have achieved results with limited clinical utility. DNA methylation (DNAm), an epigenetic modification, has been proposed to be involved in both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jiaqi, Li, Miao, Wang, Xueying, He, Yuwen, Xia, Yan, Sweeney, John A., Kopp, Richard F., Liu, Chunyu, Chen, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155631/ https://www.ncbi.nlm.nih.gov/pubmed/34054421 http://dx.doi.org/10.3389/fnins.2021.674273

Ejemplares similares

Decreased Functional Connectivity in Insular Subregions in Depressive Episodes of Bipolar Disorder and Major Depressive Disorder
por: Yin, Zhiyang, et al.
Publicado: (2018)

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Rollins, Brandi, et al.
Publicado: (2009)

Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
por: Illes, Peter, et al.
Publicado: (2020)

Slower and Less Variable Binocular Rivalry Rates in Patients With Bipolar Disorder, OCD, Major Depression, and Schizophrenia
por: Ye, Xing, et al.
Publicado: (2019)

Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder
por: Richards, Alexander L., et al.
Publicado: (2022)

Differentiation between bipolar disorder and major depressive disorder in adolescents: from clinical to biological biomarkers
por: Yang, Ruilan, et al.
Publicado: (2023)

Reduced Gray Matter Volume in Orbitofrontal Cortex Across Schizophrenia, Major Depressive Disorder, and Bipolar Disorder: A Comparative Imaging Study
por: Yang, Yongfeng, et al.
Publicado: (2022)

Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders
por: Feng, Ruiqi, et al.
Publicado: (2020)

DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder
por: Walker, Rosie May, et al.
Publicado: (2016)

Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
por: Song, Yanzhuo, et al.
Publicado: (2022)

DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder
por: Lax, Elad
Publicado: (2022)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
por: Yang, Qingxia, et al.
Publicado: (2022)

Different Frequency of Heschl’s Gyrus Duplication Patterns in Neuropsychiatric Disorders: An MRI Study in Bipolar and Major Depressive Disorders
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life
por: Li, Xiao-Hong, et al.
Publicado: (2017)

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia
por: McEvoy, Joseph, et al.
Publicado: (2019)

DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
por: Goud Alladi, Charanraj, et al.
Publicado: (2018)

Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Maier, Robert, et al.
Publicado: (2015)

Examination and Comparison of Cognitive and Executive Functions in Clinically Stable Schizophrenia Disorder, Bipolar Disorder, and Major Depressive Disorder
por: Afshari, Behrooz, et al.
Publicado: (2020)

Volumes of hippocampal subfields suggest a continuum between schizophrenia, major depressive disorder and bipolar disorder
por: Cao, Peiyu, et al.
Publicado: (2023)

DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review
por: Teroganova, Nina, et al.
Publicado: (2016)

Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression
por: Lee, Sheng-An, et al.
Publicado: (2011)

Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline
por: Hansen, Niels, et al.
Publicado: (2021)

Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis
por: Yu, Kevin, et al.
Publicado: (2010)

No association between serum cholesterol and death by suicide in patients with schizophrenia, bipolar affective disorder, or major depressive disorder
por: Park, Subin, et al.
Publicado: (2013)

A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
por: McGuinness, A. J., et al.
Publicado: (2022)

Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
por: Tao, Shiwan, et al.
Publicado: (2022)

Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research
por: Villanueva, Rosa
Publicado: (2023)

Comparative Study of Heart Rate Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder
por: Moon, Eunok, et al.
Publicado: (2013)

Resilience and Attachment in Patients with Major Depressive Disorder and Bipolar Disorder
por: Craba, Ambra, et al.
Publicado: (2023)

Bipolar Disorder and the TCI: Higher Self-Transcendence in Bipolar Disorder Compared to Major Depression
por: Harley, James A., et al.
Publicado: (2011)

Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy
por: Duan, Fangyuan, et al.
Publicado: (2022)

Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder
por: Bernstein, Hans-Gert, et al.
Publicado: (2015)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression
por: Ubhi, Kirenjeet, et al.
Publicado: (2005)

Using Summary Data from the Danish National Registers to Estimate Heritabilities for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Wray, Naomi R., et al.
Publicado: (2012)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study
por: Farrelly, Simone, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g972ugictdiolqgjq978bqh581